In this podcast episode, Mark Goldberg explores the nuances of multi-stage investing and introduces Chemistry, his innovative venture fund. He highlights the flaws in traditional venture capital, particularly how bureaucratic processes often prioritize the needs of VCs over those of founders. Goldberg emphasizes the importance of building real relationships between seasoned investors and early-stage creators. By promoting a smaller fund size and a focus on empowering founders, he aims to counteract the trends of industrialized venture capital and help unlock the true potential of promising startups.
